Stay updated on BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.

Latest updates to the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe page history now shows a new revision v3.3.4 and removes v3.3.3 from the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision note (v3.3.3) was added and an older revision note (v3.3.2) plus the HHS Vulnerability Disclosure link were removed. These changes reflect administrative footer updates.SummaryDifference0.1%

- Check51 days agoChange DetectedSite version updated from v3.2.0 to v3.3.2; no visible changes to trial data or the Record History page.SummaryDifference0.0%

- Check59 days agoChange DetectedNotice about a government funding lapse was removed from the page. This is an operational update and does not affect the trial data or history content.SummaryDifference0.3%

- Check80 days agoChange DetectedThe new screenshot primarily updates styling and layout, while the underlying version history entries and statuses remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check102 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference9%

Stay in the know with updates to BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.